Reporter Mar. 2 2012

Urine biomarker for colon cancer?

A molecule detectable in urine may be helpful in diagnosing colon cancer.

Combo combats dizziness

Some patients may need a combo of medications to combat a condition that causes dizziness.

Reversing lipid woes in cystic fibrosis

Abnormal levels of fatty acids in the blood and tissues of patients with cystic fibrosis may be reversed by supplementation with the fatty acids DHA and EPA.

‘Detangler’ binds, bends and cuts DNA

New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents.